Randomized Clinical Trial
Copyright ©The Author(s) 2022.
World J Gastroenterol. Dec 7, 2022; 28(45): 6397-6409
Published online Dec 7, 2022. doi: 10.3748/wjg.v28.i45.6397
Table 1 Baseline characteristics of the study population
Characteristic
EMR-P (n = 110), %
CEMR (n = 110), %
P value
Male (%)67 (60.9)70 (63.6)0.676
Mean age (yr, ± SD)60.4 ± 10.459.9 ± 11.50.735
Height (cm)164.4 ± 7.7165.0 ± 7.50.566
Weight (kg)61.4 ± 10.563.5 ± 10.70.151
Location, n (%)0.725
      Cecum6 (5.5)5 (4.5)
      Ascending19 (17.3)18 (16.4)
      Transverse24 (21.8)28 (25.5)
      Descending7 (6.4)9 (8.2)
      Sigmoid26 (23.6)31 (28.2)
      Rectum28 (25.5)19 (17.3)
Morphology, n (%)0.858
      0-Ip3 (2.7)3 (2.7)
      0-Is36 (32.7)42 (38.2)
      0-IIa68 (61.8)62 (56.4)
      0-IIb2 (1.8)3 (2.7)
      0-IIc1 (0.9)0 (0.0)
Institution, n (%)0.570
      A16 (14.5)9 (8.2)
      B31 (28.2)28 (25.5)
      C6 (5.5)5 (4.5)
      D19 (17.3)16 (14.5)
      E9 (8.2)14 (12.7)
      F13 (11.8)18 (16.4)
      G16 (14.5)20 (18.2)
Tumor size (mm)14.0 ± 3.713.1 ± 3.10.055
Operator experience, n (%)0.072
      Experienced endoscopist109 (99.1)103 (93.6)
      Non-experienced endoscopist1 (0.9)7 (6.4)